$XFLH SEC Filings

Filed On	Filing
06 Oct 2026	SCHEDULE 13G
22 Sep 2026	8-K: Entry into a Material Definitive Agreement; Other Events XFLH Capital Corporation Announces the Signing of a Letter of Intent with Renogen Biolab Inc.
13 Jul 2026	FORM 10-Q
15 May 2026	SCHEDULE 13G
08 May 2026	SCHEDULE 13G
14 Apr 2026	FORM 10-Q
07 Apr 2026	SCHEDULE 13G
31 Mar 2026	Form 4: Xflh Holdings Ltd, 10% owner Returned 500,000 shares to the issuer
04 Mar 2026	8-K: Other Events
20 Feb 2026	8-K: Other Events
19 Feb 2026	SCHEDULE 13G
17 Feb 2026	Form 4: Xflh Holdings Ltd, 10% owner Bought 154,970 shares ($1.55M) · Acquired 154,970 Rights to receive ordinary shares (Open Market Purchase)
17 Feb 2026	8-K: Entry into a Material Definitive Agreement; Unregistered Sales of Equity Securities +2 more
12 Feb 2026	FORM 424B4
11 Feb 2026	Form 3: Wong Heung Ming Henry, Director Holds 30,000 shares of Ordinary Shares, $0.0001
11 Feb 2026	Form 3: Yang Yanzhe, Director Holds 40,000 shares of Ordinary Shares, $0.0001
11 Feb 2026	Form 3: Yang Tianshi, Chief Financial Officer Holds 40,000 shares of Ordinary Shares, $0.0001
11 Feb 2026	Form 3: Xflh Holdings Ltd, 10% owner Holds 3,663,333 shares of Ordinary Shares, $0.0001
11 Feb 2026	Form 3: Cheng Jonathan Yee Fung, Director Holds 30,000 shares of Ordinary Shares, $0.0001
11 Feb 2026	Form 3: Huang Chennong, Director Holds 30,000 shares of Ordinary Shares, $0.0001

Comments